|
DYNC1LI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.571770E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.322300E-03 |
| Normal-vs-Stage2 |
1.300240E-01 |
| Normal-vs-Stage3 |
2.164000E-01 |
| Normal-vs-Stage4 |
5.329200E-01 |
| Stage1-vs-Stage2 |
7.805800E-01 |
| Stage1-vs-Stage3 |
8.952000E-01 |
| Stage1-vs-Stage4 |
1.353230E-01 |
| Stage2-vs-Stage3 |
7.735800E-01 |
| Stage2-vs-Stage4 |
1.507240E-01 |
| Stage3-vs-Stage4 |
2.586800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.573490E-04 |
| Normal-vs-AfricanAmerican |
1.003590E-01 |
| Normal-vs-Asian |
4.374200E-01 |
| Caucasian-vs-AfricanAmerican |
1.536000E-01 |
| Caucasian-vs-Asian |
6.863600E-01 |
| AfricanAmerican-vs-Asian |
6.173400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.573700E-04 |
| Normal-vs-Female |
1.455820E-02 |
| Male-vs-Female |
7.805200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.201400E-01 |
| Normal-vs-Extreme_Weight |
8.822000E-02 |
| Normal-vs-Obese |
2.744700E-03 |
| Normal-vs-Extreme_Obese |
6.606800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.482400E-01 |
| Normal_Weight-vs-Obese |
3.479900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.640600E-01 |
| Extreme_Weight-vs-Obese |
1.115570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.355200E-01 |
| Obese-vs-Extreme_Obese |
3.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.785600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.188250E-04 |
| Normal-vs-Age(61-80Yrs) |
7.422000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.769400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.009400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.525800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.946300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.430610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.941600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.909800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.75150000017943E-07 |
| Normal-VS-Type2 PRCC |
8.263200E-01 |
| Normal-VS-KIRP CIMP |
3.769600E-01 |
| Normal-VS-Unclassified PRCC |
1.415990E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.55740000000027E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.003400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.054600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.375800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.412340E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.203600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.529800E-01 |
| Normal-vs-N1 |
1.355650E-01 |
| Normal-vs-N2 |
1.584010E-02 |
| N0-vs-N1 |
8.028400E-01 |
| N0-vs-N2 |
1.981200E-01 |
| N1-vs-N2 |
4.878000E-02 |
|
|
